Position in GILD
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$1,638,755
-$139,606 QoQ
Shares Held
12,971
+1.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#895
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GHP Investment Advisors, Inc. holds $46,475,498 across 14 Drug Manufacturers - General names. GILD ranks #5 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
118,345 | $15,207,332 | |
| 2 | JNJ |
Johnson & Johnson
|
58,033 | $14,738,640 | |
| 3 | AMGN |
Amgen Inc
|
28,143 | $10,191,142 | |
| 4 | LLY |
ELI LILLY & Co
|
1,816 | $2,178,165 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
12,971 | $1,638,755 | |
| 6 | ABBV |
AbbVie Inc.
|
5,799 | $1,459,260 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
5,952 | $342,954 | |
| 8 | NVO |
Novo Nordisk A S
|
4,826 | $231,358 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,638,755 | 12,971 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $1,778,361 | 12,760 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $1,551,679 | 12,642 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $1,406,259 | 12,669 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $1,387,316 | 12,513 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $1,388,187 | 12,389 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $1,048,768 | 11,354 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $941,690 | 11,232 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $727,334 | 10,601 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $811,024 | 11,072 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $885,277 | 10,928 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $802,832 | 10,713 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $911,429 | 11,826 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $954,735 | 11,507 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $941,688 | 10,969 | Shares | Sole | 2023-02-16 | |
| 2022-09-30 | $552,187 | 8,951 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $543,804 | 8,798 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $473,578 | 7,966 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $616,531 | 8,491 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $536,797 | 7,685 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $485,600 | 7,052 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $499,783 | 7,733 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $443,824 | 7,618 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $606,181 | 9,593 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $859,573 | 11,172 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $710,444 | 9,503 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||